Richard Chin | Chief Executive Officer |
Denise Bevers | President & Chief Operating Officer |
Wendy Wee | Chief Financial Officer |
Brandon Folkes | Cantor Fitzgerald |
Ben Haynor | Alliance Global Partners |
Andrew DeSilva | B. Riley FBR |
Swayampakula Ramakanth | H.C. Wainwright |
Brooks O'Neil | Lake Street Capital Markets |
David Westenberg | Guggenheim Securities |
Welcome to the Fourth Quarter and Full Year 2018 Financial Results Conference Call and Webcast for Kindred Biosciences. At this time, all participants have been placed on listen-only mode. At the end of prepared statements, participants will have the opportunity to ask questions. [Operator Instructions] Please note that the remarks today will include forward-looking statements and that actual results could differ materially from those projected or implied in our forward-looking statements.
For a description of important factors that could cause actual results to differ, we refer you to the forward-looking statements in today's press release and the note on forward-looking statements in the company's SEC filings.